Atara Biotherapeutics Stock In The News
| ATRA Stock | USD 13.33 1.13 9.26% |
Our overall analysis of Atara Biotherapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Atara Biotherapeutics. The specific impact of Atara Biotherapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Atara Biotherapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Atara Biotherapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Atara Biotherapeutics Backtesting and Atara Biotherapeutics Hype Analysis. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.
Atara |
Atara Biotherapeutics Today Top News and Investor Outlook
Atara Biotherapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Atara and other traded companies coverage with news coverage. We help investors stay connected with Atara headlines for the 25th of December to make an informed investment decision based on correlating the impacts of news items on Atara Stock performance. Please note that trading solely based on the Atara Biotherapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Atara Biotherapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Atara earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Atara Biotherapeutics that are available to investors today. That information is available publicly through Atara media outlets and privately through word of mouth or via Atara internal channels. However, regardless of the origin, that massive amount of Atara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Atara Biotherapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Atara Biotherapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Atara Biotherapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Atara Biotherapeutics alpha.
Atara Largest EPS Surprises
Earnings surprises can significantly impact Atara Biotherapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.26 | -0.23 | 0.03 | 11 | ||
2024-03-28 | 2023-12-31 | -0.48 | -0.56 | -0.08 | 16 | ||
2022-05-05 | 2022-03-31 | -0.98 | -0.87 | 0.11 | 11 | ||
2016-11-04 | 2016-09-30 | -0.77 | -0.88 | -0.11 | 14 | ||
2018-05-08 | 2018-03-31 | -0.92 | -1.05 | -0.13 | 14 | ||
2015-11-05 | 2015-09-30 | -0.56 | -0.43 | 0.13 | 23 |
Atara Biotherapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Atara Biotherapeutics Stock. Current markets are strongly bullish. About 82% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of December 2024
Allogeneic T Cell Therapies Market Report, 2024-2028 2033 - Valued at 1.16 Billion in 2024... at finance.yahoo.com
22nd of November 2024
Insider Selling Atara Biotherapeutics, Inc. CEO Sells 1,664 Shares of Stock at thelincolnianonline.com
20th of November 2024
FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Ce... at finance.yahoo.com
19th of November 2024
LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative A... at finance.yahoo.com
15th of November 2024
Atara Biotherapeutics Third Quarter 2024 Earnings Beats Expectations at simplywall.st
13th of November 2024
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference at businesswire.com
12th of November 2024
Atara Biotherapeutics Reports Q3 Loss, Tops Revenue Estimates at zacks.com
5th of November 2024
Vanguard Group Incs Strategic Acquisition in Atara Biotherapeutics Inc at gurufocus.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atara Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atara Biotherapeutics' short interest history, or implied volatility extrapolated from Atara Biotherapeutics options trading.
Check out Atara Biotherapeutics Backtesting and Atara Biotherapeutics Hype Analysis. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherapeutics. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atara Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (25.32) | Revenue Per Share 12.263 | Quarterly Revenue Growth 28.927 | Return On Assets (0.57) | Return On Equity (20.15) |
The market value of Atara Biotherapeutics is measured differently than its book value, which is the value of Atara that is recorded on the company's balance sheet. Investors also form their own opinion of Atara Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Atara Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atara Biotherapeutics' market value can be influenced by many factors that don't directly affect Atara Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atara Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atara Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atara Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.